JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B4669 Vidofludimus

Summary: DHODH inhibitor

insoluble in H2O; insoluble in EtOH; ≥103 mg/mL
B4671 APD668

Summary: Potent GPR119 agonist

insoluble in H2O; ≥17.4 mg/mL
B4675 GW311616

Summary: inhibitor of human neutrophil elastase(HNE)

Soluble in DMSO
B4676 GW311616 hydrochloride

Summary: HNE inhibitor

≥21.7 mg/mL
B4677 NVP-CGM097

Summary: potent and selective MDM2 inhibitor

Soluble in DMSO
B4678 CPI-169
1 Citation

Target: EZH2|EZH1

Summary: EZH2 inhibitor

≥26.45 mg/mL
B4686 TAPI-1
2 Citation

Target: MMP

Summary: TACE/ADAM17 inhibitor

≥24.98 mg/mL
B4687 iCRT 14

Summary: CRT inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
B4688 3CAI

Summary: AKT inhibitor

insoluble in EtOH; insoluble in H2O; ≥6.8 mg/mL
B4694 PSN632408

Summary: Human and mouse GPR119 agonist

Soluble in DMSO